Items

FDA approves $5 rapid coronavirus test that doesn't require special computer

The Food and Drug Administration on Wednesday authorized the first rapid coronavirus test that doesn't need any special computer equipment to get results.

The 15-minute BinaxNOW test from Abbott Laboratories will sell for $5, giving it a competitive edge over similar tests that need to be popped into a small machine. The self-contained test is the size of a credit card and is based on the same technology used to test for the flu, strep throat and other infections.

Submitted by mo2 on Fri, 08/28/2020 - 03:00
Putin says Russia has approved 'world first' Covid-19 vaccine. But questions over its safety remain

Moscow Russian President Vladimir Putin announced the approval of a coronavirus vaccine for use on Tuesday, claiming it as a "world first," amid continued concern and unanswered questions over its safety and effectiveness.

Submitted by mo2 on Wed, 08/12/2020 - 19:12
Gates Foundation Teams Up With Vaccine Maker to Produce $3 Covid-19 Shots

As U.S. and other governments sign deals for vaccine supplies, Gates, Gavi and Serum Institute of India pledge cheap shots for developing world

The Bill & Melinda Gates Foundation said it is backing the world’s largest vaccine maker, Serum Institute of India, to churn out 100 million doses of coronavirus vaccine for poorer countries and price them at less than $3.

Submitted by mo2 on Fri, 08/07/2020 - 18:12
CDC documents say states should prepare to distribute Covid-19 vaccines as soon as late October

The US Centers for Disease Control and Prevention has told public health officials around the United States to prepare to distribute a potential coronavirus vaccine as soon as late October. It also provided planning scenarios to help states prepare.

Submitted by mo2 on Mon, 07/27/2020 - 21:28
Dr. Anthony Fauci isn't 'particularly concerned' about the safety of Moderna coronavirus vaccine
  • White House coronavirus advisor Dr. Anthony Fauci said Monday he is "not particularly concerned" about the safety risk of a potential coronavirus vaccine by Moderna, despite the fact that it uses new technology to fight the virus. 
  • The vaccine, which entered a large phase-three human trial Monday, uses messenger ribonucleic acid, or mRNA molecules, to provoke an immune response to fight the virus.
Submitted by mo2 on Mon, 07/27/2020 - 20:58